Page 61 - AN-3-2

Advanced Neurology Inflammation in diabetic stroke: Pathogenesis

in diabetic patients. Diabetes Care. 1991;14(1):63-65. doi: 10.1186/s12974-017-0796-7
doi: 10.2337/diacare.14.1.63 81. Fang M, Zhong L, Jin X, et al. Effect of inflammation on the
process of stroke rehabilitation and poststroke depression.
73. Tessaro FHG, Ayala TS, Nolasco EL, Bella LM, Martins JO. Front Psychiatry. 2019;10:184.
Insulin influences LPS-induced TNF-alpha and IL-6
release through distinct pathways in mouse macrophages doi: 10.3389/fpsyt.2019.00184
from different compartments. Cell Physiol Biochem. 82. Hu Y, Zheng Y, Wu Y, Ni B, Shi S. Imbalance between
2017;42(5):2093-2104. IL-17A-producing cells and regulatory T cells during
doi: 10.1159/000479904 ischemic stroke. Mediators Inflamm. 2014;2014:813045.
74. Liu HF, Zhang HJ, Hu QX, et al. Altered polarization, doi: 10.1155/2014/813045
morphology, and impaired innate immunity germane to 83. Becker KJ. Inflammation and the silent sequelae of stroke.
resident peritoneal macrophages in mice with long-term Neurotherapeutics. 2016;13(4):801-810.
type 2 diabetes. J Biomed Biotechnol. 2012;2012:867023.
doi: 10.1007/s13311-016-0451-5
doi: 10.1155/2012/867023
84. Wen H, Weymann KB, Wood L, Wang QM. Inflammatory
75. Restrepo BI, Twahirwa M, Rahbar MH, Schlesinger LS. signaling in post-stroke fatigue and depression. Eur Neurol.
Phagocytosis via complement or Fc-gamma receptors is 2018;80(3-4):138-148.
compromised in monocytes from type 2 diabetes patients
with chronic hyperglycemia. PLoS One. 2014;9(3):e92977. doi: 10.1159/000494988
85. O’Connor JC, Satpathy A, Hartman ME, et al. IL-1beta-
doi: 10.1371/journal.pone.0092977
mediated innate immunity is amplified in the db/db mouse
76. Schepers VP, Visser-Meily AM, Ketelaar M, Lindeman E. model of type 2 diabetes. J Immunol. 2005;174(8):4991-4997.
Poststroke fatigue: Course and its relation to personal doi: 10.4049/jimmunol.174.8.4991
and stroke-related factors. Arch Phys Med Rehabil.
2006;87(2):184-188. 86. Pendlebury ST, Rothwell PM, Oxford Vascular Study.
Incidence and prevalence of dementia associated with
doi: 10.1016/j.apmr.2005.10.005 transient ischaemic attack and stroke: Analysis of the
77. Christensen D, Johnsen SP, Watt T, Harder I, Kirkevold M, population-based Oxford Vascular Study. Lancet Neurol.
Andersen G. Dimensions of post-stroke fatigue: A two-year 2019;18(3):248-258.
follow-up study. Cerebrovasc Dis. 2008;26(2):134-141. doi: 10.1016/S1474-4422(18)30442-3
doi: 10.1159/000139660 87. Shang Y, Fratiglioni L, Marseglia A, et al. Association
78. Alghamdi I, Ariti C, Williams A, Wood E, Hewitt J. of diabetes with stroke and post-stroke dementia:
Prevalence of fatigue after stroke: A systematic review and A population-based cohort study. Alzheimers Dement.
meta-analysis. Eur Stroke J. 2021;6(4):319-332. 2020;16(7):1003-1012.
doi: 10.1177/23969873211047681 doi: 10.1002/alz.12101
79. Hackett ML, Pickles K. Part I: Frequency of depression after 88. Doyle KP, Buckwalter MS. Does B lymphocyte-mediated
stroke: An updated systematic review and meta-analysis of autoimmunity contribute to post-stroke dementia? Brain
observational studies. Int J Stroke. 2014;9(8):1017-1025. Behav Immun. 2017;64:1-8.
doi: 10.1111/ijs.12357 doi: 10.1016/j.bbi.2016.08.009
80. Roerink ME, van der Schaaf ME, Dinarello CA, Knoop H, 89. Belkhelfa M, Beder N, Mouhoub D, et al. The involvement
van der Meer JW. Interleukin-1 as a mediator of fatigue of neuroinflammation and necroptosis in the hippocampus
in disease: A narrative review. J Neuroinflammation. during vascular dementia. J Neuroimmunol. 2018;320:48-57.
2017;14(1):16. doi: 10.1016/j.jneuroim.2018.04.004

Volume 3 Issue 2 (2024) 11 doi: 10.36922/an.1683